DeepMed Research

DARTMOUTH-HITCHCOCK MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1983-01-01

Employees: 10K

Market Cap: -

Website: http://www.dartmouth-hitchcock.org

Clinical Trials

Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSF

Phase 1

Completed

Conditions: Non-Hodgkin's Lymphoma
Hodgkin's Disease
Multiple Myeloma
Other Plasma Cell Dyscrasia (Waldenstrom, Amyloidosis)
Leukemia

Interventions: Drug: GM-CSF
Drug: IL-2

First Posted Date: 2009-08-06

Last Posted Date: 2018-04-25

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 13

Registration Number: NCT00952237

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Protocol to Obtain Bone Marrow for Research

Completed

Conditions: Bone Marrow Biopsy

Interventions: Other: Bone Marrow Aspirate Draw

First Posted Date: 2009-08-04

Last Posted Date: 2019-03-06

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 28

Registration Number: NCT00951925

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors

Phase 1

Terminated

Conditions: Advanced Solid Tumors

Interventions: Drug: Conjugated Linoleic Acid

First Posted Date: 2009-08-04

Last Posted Date: 2015-05-12

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 4

Registration Number: NCT00951158

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Cannabis and Schizophrenia: Self-Medication and Agonist Treatment

Phase 1

Completed

Conditions: Cannabis Use Disorder
Psychotic Disorder
Schizophrenia
Dual Diagnosis
Schizoaffective Disorder

Interventions: Drug: Dronabinol
Drug: Cannabis

First Posted Date: 2009-07-27

Last Posted Date: 2021-07-12

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 12

Registration Number: NCT00946348

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire, United States

Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas

Completed

Conditions: Recurrent High Grade Gliomas

Interventions: Device: 3T MRI

First Posted Date: 2009-07-21

Last Posted Date: 2013-05-08

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 12

Registration Number: NCT00942760

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients

Phase 2

Terminated

Conditions: Metastatic Renal Cell Carcinoma

Interventions: Biological: DC vaccine
Drug: Bevacizumab
Biological: IL-2
Biological: IFN

First Posted Date: 2009-06-04

Last Posted Date: 2015-12-01

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 8

Registration Number: NCT00913913

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue

Early Phase 1

Completed

Conditions: Breast Cancer

Interventions: Drug: Conjugated Linoleic Acid (CLA)

First Posted Date: 2009-05-27

Last Posted Date: 2019-04-01

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 24

Registration Number: NCT00908791

Locations: 🇺🇸
Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Intra-operative Ketamine Infusions in Opioid-dependent Patients With Chronic Lower Back Pain

Not Applicable

Completed

Conditions: Chronic Low Back Pain

Interventions: Drug: Ketamine
Other: Normal saline

First Posted Date: 2009-05-12

Last Posted Date: 2018-10-18

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 102

Registration Number: NCT00899600

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Protocol to Obtain Blood Samples for Leukemia Research

Completed

Conditions: Chronic Lymphocytic Leukemia

Interventions: Other: No Intervention

First Posted Date: 2009-04-28

Last Posted Date: 2020-04-07

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 187

Registration Number: NCT00889031

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation

Completed

Conditions: Lymphoma

First Posted Date: 2009-04-28

Last Posted Date: 2018-05-22

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 30

Registration Number: NCT00889278

Locations: 🇺🇸
Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy